Involvement of cytokines and inflammation in catecholamine-induced pulmonary injury in rats

Vascular Disease Prevention

Volumn 2, Issue 1, 2005, Pages 1-9

  Rassler, Beate ^a   Rohling, Marc A ^a   Reissig, Christian ^a   Briest, Wilfried ^a   Tannapfel, Andrea ^b   Zimmer, Heinz Gerd ^a  

^a Carl Ludwig Institute of Physiology   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Bronchoalveolar lavage; Cardiac hypertrophy; Catecholamines; Cytokines; Pulmonary inflammation; Pulmonary oedema; Pulmonary vascular hypertrophy

Indexed keywords

CATECHOLAMINE; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOPRENALINE; MESSENGER RNA; NORADRENALIN; PHENYLEPHRINE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; FEMALE; HEART FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HISTOLOGY; HYPERTROPHY; INFLAMMATION; LUNG DISEASE; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; LUNG VASCULAR HYPERTROPHY; MACROPHAGE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PLEURA FLUID; PRIORITY JOURNAL; RAT; STIMULATION; VASCULAR DISEASE;

EID: 20044392913     PISSN: 15672700     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567270052774395     Document Type: Article

References (37)

1. De Leeuw PW, Waltman FL, Birkenhäger WH: Non-cardiogenic pulmonary edema as the sole manifestation of pheochromocytoma. Hypertension 1986; 8: 810-812.
2. van Iperen CE, Giezen J, Kramer WLM, Lips CJM, Bartelink AKM. Acute dyspnoea resulting from pulmonary edema as the first sign of a phaeochromocytoma. Respiration 2001; 68: 323-326.
3. Theodore J, Robin ED. Pathogenesis of neurogenic pulmonary edema. Lancet 1975; 2: 749-751.
4. Colice GL, Matthay MA, Bass E, Matthay RA. Neurogenic pulmonary edema. Am Rev Respir Dis 1984; 130: 941-948.
5. Kubo K, Hanaoka M, Hayano T, et al. Inflammatory cytokines in BAL fluid and pulmonary hemodynamics in high-attitude pulmonary edema. Respir Physiol 1998; 111: 301-310.
6. Hartmann G, Tschöp M, Fischer R, et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 2000; 12: 246-252.
7. Rassler B, Barth W, Zimmer H-G. Transient pleural effusion in norepinephrine-stimulaled rats. Basic Res Cardiol 2001; 96: 265-273.
8. Rassler B, Reissig C, Briest W, Tannapfel A, Zimmer H-G. Catecholamine-induced pulmonary edema and pleural effusion in rats - α- and β-adrenergic effects. Resp Physiol Neurobiol 2003; 135: 25-37.
9. Molina PE, Malek S, Lang CH, Qian L, Naukam R, Abumrad NN. Early organ-specific hemorrhage-induced increases in tissue cytokine content: associated neurohormonal and opioid alterations. Neuroimmunomodulation 1997; 4: 28-36.
10. Molina PE, Abumrad NN. Differential effects of hemorrhage and LPS on tissue TNF-alpha, IL-1 and associate neuro-hormonal and opioid alterations. Life Sci 2000; 66: 399-409.
11. Bergmann M, Sautner T. Immunomodulatory effects of vasoactive catecholamines. Wien Klin Wochenschr 2002; 114: 752-761.
12. van Gool J, van Vugt H, Helle M, Aarden LA. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopath 1990; 57: 200-210.
13. Broug-Holub E, Persoons JH, Schornagel K, Mastbergen SC, Kraal G. Effects of stress on alveolar macrophages: a role for the sympathetic nervous system. Am J Respir Cell Mol Biol 1998; 19: 842-848.
14. Barth W, Deten A, Bauer M, Reinohs M, Leicht M, Zimmer H-G. Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen. J Mol Cell Cardiol 2000; 32: 273-284.
15. Schütte H, Lohmeyer J, Rosseau S, et al. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary edema. Eur Respir J 1996; 9: 1858-1867.
16. Rixen D, Siegel JH. Metabolic correlates of oxygen debt predict posttrauma early acute respiratory distress syndrome and the related cytokine response. J Trauma 2000; 49: 392-403.
17. Mazzeo RS, Donovan D, Fleshner M, et al. Interleukin-6 response to exercise and high-altitude exposure: influence of α-adrenergic blockade. J Appl Physiol 2001; 91: 2143-2149.
18. Gillespie MN, Goldblum SE, Cohen DA, McClain CJ. Interleukin 1 bioactivity in the lungs of rats with monocrotaline-induced pulmonary hypertension. Proc Soc Exp Biol Med 1988; 187: 26-32.
19. Voelkel NF, Tuder RM, Bridges J, Arend WP. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol 1994; 11: 664-675.
20. 1-Adrenergic hypothesis for pulmonary hypertension. Chest 1999; 115: 1708-1719.
21. Brusselmans K, Compernolle V, Tjwa M, et al. Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest 2003; 111: 1519-1527.
22. Zaloga GP, Chernow B, Fletcher JR, Hughes P, Rainey TG, Lake CR. Increased circulating plasma norepineplirine concentrations in noncardiac causes of pulmonary hypertension. Crit Care Med 1984; 12: 85-89.
23. Knirsch W, Eiselt M, Nurnberg J, et al. Pulmonary plasma catecholamine levels and pulmonary hypertension in congenital heart disease. Z Kardiol 2002; 91: 1035-1043.
24. Bratel T, Wennlund A, Carlstrom K. Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD). Effects of long-term oxygen treatment. Respir Med 2000; 94: 1221-1228.
25. Nakaki T, Nakayama M, Yamamoto S, Kato R. Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol 1990; 37: 30-36.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Bioehem 1987; 162: 156-159.
27. Rassler B, Reissig C, Briest W, Tannapfel A, Zimmer H-G. Pulmonary edema and pleural effusion in norepinephrine-stimulated rats-hemodynamic or inflammatory effect. Mol Cell Biochem 2003; 250: 55-63.
28. Laffon M, Lu LN, Modelska K, Matthay MA, Pittet JF. α-Adrenergic blockade restores normal fluid transport capacity of alveolar epithelium after hemorrhagic shock. Am J Physiol 1999; 277: L760-768.
29. Song DK, Im YB, Jung JS, et al. Differential involvement of central and peripheral norepinephrine in the central lipopolysaccharide-induced interleukin-6 responses in mice. J Neurochem 1999; 72: 1625-1633.
30. Kleger GR, Bärtsch P, Voek P, Heilig B, Roberts LJ 2nd, Ballmer PE. Evidence against an increase in capillary permeability in subjects exposed to high altitude. J Appl Physiol 1996; 81: 1917-1923.
31. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 1991; 285: 199-212.
32. Mizuhara H, O'Neill E, Seki N, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179: 1529-1537.
33. Matthys P, Mitera T, Heremans H, Van Damme J, Billiau A. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect Immun 1995; 63: 1158-1164.
34. Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 2003; 17: 884-886.
35. Fan JM, Huang XR, Ng YY, et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis 2001; 37: 820-831.
36. Miyata M, Ito M, Sasajima T, Ohira H, Kasukawa R. Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats. Chest 2001; 119: 554-561.
37. Bolster MB, Ludwicka A, Sutherland SE, Strange C, Silver RM. Cytokine concentrations in broncho-alveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum 1997; 40: 743-751.